Hecht M - Search Results

1

Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry.

Schramm A, Ndayisaba JP, Auf dem Brinke M, Hecht M, Herrmann C, Huber M, Lobsien E, Mehnert S, Reuter I, Stenner A, van der Ven C, Winterholler M, Kupsch A, Wissel J. Schramm A, et al. Among authors: hecht m. J Neural Transm (Vienna). 2014 May;121(5):521-30. doi: 10.1007/s00702-013-1145-3. Epub 2014 Jan 10. J Neural Transm (Vienna). 2014. PMID: 24407377 Clinical Trial.

2

Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study.

Hecht MJ, Birklein F, Winterholler M. Hecht MJ, et al. Arch Dermatol Res. 2004 Feb;295(8-9):318-9. doi: 10.1007/s00403-003-0440-5. Epub 2003 Nov 29. Arch Dermatol Res. 2004. PMID: 14648075 Clinical Trial. No abstract available.

3

Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia--report of 19 cases.

Hecht MJ, Stolze H, Auf dem Brinke M, Giess R, Treig T, Winterholler M, Wissel J; German Spasticity Education Group. Hecht MJ, et al. Mov Disord. 2008 Jan 30;23(2):228-33. doi: 10.1002/mds.21809. Mov Disord. 2008. PMID: 17999430

4

[Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Wissel J, auf dem Brinke M, Hecht M, Herrmann C, Huber M, Mehnert S, Reuter I, Schramm A, Stenner A, van der Ven C, Winterholler M, Kupsch A. Wissel J, et al. Among authors: hecht m. Nervenarzt. 2011 Apr;82(4):481-95. doi: 10.1007/s00115-010-3172-8. Nervenarzt. 2011. PMID: 21079908 German.

5

[Survival with artificial respiration at home. An open, prospective study on home ventilation for neuromuscular diseases, in particular, the situation of ALS patients].

Winterholler MG, Erbguth FJ, Hecht MJ, Heuss D, Neundörfer B. Winterholler MG, et al. Among authors: hecht mj. Nervenarzt. 2001 Apr;72(4):293-301. doi: 10.1007/s001150050753. Nervenarzt. 2001. PMID: 11320865 German.

6

Recurrent trismus and stridor in an ALS patient: successful treatment with botulinum toxin.

Winterholler MG, Heckmann JG, Hecht M, Erbguth FJ. Winterholler MG, et al. Among authors: hecht m. Neurology. 2002 Feb 12;58(3):502-3. doi: 10.1212/wnl.58.3.502. Neurology. 2002. PMID: 11839868 No abstract available.

7

Botulinum toxin in patients with multiple sclerosis.

Kabus C, Hecht M, Japp G, Jost WH, Pöhlau D, Stuckrad-Barre S, Winterholler M. Kabus C, et al. Among authors: hecht m. J Neurol. 2006 Feb;253 Suppl 1:I26-8. doi: 10.1007/s00415-006-1106-y. J Neurol. 2006. PMID: 16477482

8

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.

Wissel J, Bensmail D, Ferreira JJ, Molteni F, Satkunam L, Moraleda S, Rekand T, McGuire J, Scheschonka A, Flatau-Baqué B, Simon O, Rochford ET, Dressler D, Simpson DM; TOWER study investigators. Wissel J, et al. Neurology. 2017 Apr 4;88(14):1321-1328. doi: 10.1212/WNL.0000000000003789. Epub 2017 Mar 10. Neurology. 2017. PMID: 28283596 Free PMC article.

9

Subjective experience and coping in ALS.

Hecht M, Hillemacher T, Gräsel E, Tigges S, Winterholler M, Heuss D, Hilz MJ, Neundörfer B. Hecht M, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002 Dec;3(4):225-31. doi: 10.1080/146608202760839009. Amyotroph Lateral Scler Other Motor Neuron Disord. 2002. PMID: 12710513

10

Burden of care in amyotrophic lateral sclerosis.

Hecht MJ, Graesel E, Tigges S, Hillemacher T, Winterholler M, Hilz MJ, Heuss D, Neundörfer B. Hecht MJ, et al. Palliat Med. 2003 Jun;17(4):327-33. doi: 10.1191/0269216303pm754oa. Palliat Med. 2003. PMID: 12822849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

614 results

Search Page

Filters